ArticleBioprocess and biosystems engineering2025
Dual roles of anion exchange resin in green lignocellulose biorefinery system based on self-providing acid pretreatment.
Article in Bioprocess and biosystems engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Resting cell-catalyzed xylonic acid (XA) offers a promising strategy for developing an efficient lignocellulose biorefinery that relies on a systematic self-providing acid pretreatment. Xylo-oligosaccharides, XA, and glucose are co-produced from hemicellulose and cellulose components through a combination of XA pretreatment corncob, resting cell catalysis of xylose, and enzymatic hydrolysis of cellulose. However, the inevitable formation of degraded inhibitors and XA can synergistically impede biological processes during XA recycling and pretreatment. An anion exchange resin serves a dual function role, acting as an intelligent regulator of inhibitors and XA in the resting cell catalysis of pretreated hydrolysates, and efficiently facilitating the centrifugal separation and recycling of bacterial cells for xylose conversion to XA. After five consecutive rounds of co-recovery of the resin and bacterial cells, 91.6% of the bacteria remained viable, and the xylose conversion to XA yield reached 82.2%.
Indexed as
Identifiers
40244461What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.